These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 36129672)
1. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas. He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672 [TBL] [Abstract][Full Text] [Related]
2. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma. Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A Front Immunol; 2022; 13():961933. PubMed ID: 35990696 [TBL] [Abstract][Full Text] [Related]
3. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration. Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094 [TBL] [Abstract][Full Text] [Related]
4. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma. Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808 [No Abstract] [Full Text] [Related]
5. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma. Chen J; Chen S; Li B; Zhou S; Lin H Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280 [TBL] [Abstract][Full Text] [Related]
6. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma. Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070 [TBL] [Abstract][Full Text] [Related]
7. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q Front Immunol; 2022; 13():1011757. PubMed ID: 36325335 [TBL] [Abstract][Full Text] [Related]
8. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes. Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452 [TBL] [Abstract][Full Text] [Related]
9. Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma. Wang J; Ren J; Liu J; Zhang L; Yuan Q; Dong B Bosn J Basic Med Sci; 2022 Sep; 22(5):728-750. PubMed ID: 35276059 [TBL] [Abstract][Full Text] [Related]
10. Caspase-4 in glioma indicates deterioration and unfavorable prognosis by affecting tumor cell proliferation and immune cell recruitment. Di L; Li M; Lei X; Xie W; Liu G; Wang Y; Zhang W; Zhu WG Sci Rep; 2024 Jul; 14(1):17443. PubMed ID: 39075190 [TBL] [Abstract][Full Text] [Related]
11. A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer. Li L; Li Y; Lin J; Pang W Technol Cancer Res Treat; 2024; 23():15330338241277584. PubMed ID: 39155627 [TBL] [Abstract][Full Text] [Related]
12. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma. He J; Zhou W; Zhang M Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887 [TBL] [Abstract][Full Text] [Related]
13. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation. Gong M; Liu X; Zhao X; Wang H BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348 [TBL] [Abstract][Full Text] [Related]
14. Predicting the prognosis of glioma by pyroptosis-related signature. Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605 [TBL] [Abstract][Full Text] [Related]
15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients. Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
18. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma. Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas. Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J Front Genet; 2023; 14():1087563. PubMed ID: 36861130 [No Abstract] [Full Text] [Related]
20. Identification of a pyroptosis-related prognosis gene signature and its relationship with an immune microenvironment in gliomas. Xiao S; Yan Z; Zeng F; Lu Y; Qiu J; Zhu X Medicine (Baltimore); 2022 Jul; 101(28):e29391. PubMed ID: 35839032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]